Formycon AG/€FYB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Formycon AG
Formycon AG is a biotechnology company based in Planegg, Germany, specializing in the development of biosimilar products. The company focuses primarily on creating biosimilar versions of top-selling biopharmaceuticals, addressing fields such as ophthalmology and immunology. Known for its significant expertise in protein and biopharmaceutical development, Formycon leverages its proprietary technical platform to advance its biosimilar pipeline. The company's strategic positioning includes partnerships with other pharmaceutical firms to co-develop and commercialize its biosimilar candidates. Formycon's competitive strength lies in its robust development capabilities and focus on high-growth therapeutic areas.
Ticker
€FYB
Sector
Primary listing
XETRA
Employees
250
Headquarters
Website
Formycon AG Metrics
BasicAdvanced
€448M
-
-€7.18
0.60
-
Price and volume
Market cap
€448M
Beta
0.6
52-week high
€64.40
52-week low
€19.18
Average daily volume
17K
Financial strength
Current ratio
2.804
Quick ratio
2.143
Long term debt to equity
1.97
Total debt to equity
2.294
Interest coverage (TTM)
-21.55%
Profitability
EBITDA (TTM)
114.139
Gross margin (TTM)
21.29%
Net profit margin (TTM)
-180.37%
Operating margin (TTM)
-33.68%
Effective tax rate (TTM)
12.88%
Revenue per employee (TTM)
€280,000
Management effectiveness
Return on assets (TTM)
-1.76%
Return on equity (TTM)
-26.06%
Valuation
Price to revenue (TTM)
6.352
Price to book
0.97
Price to tangible book (TTM)
25.25
Price to free cash flow (TTM)
-8.325
Free cash flow yield (TTM)
-12.01%
Free cash flow per share (TTM)
-3.039
Growth
Revenue change (TTM)
-10.32%
Earnings per share change (TTM)
-252.22%
3-year revenue growth (CAGR)
23.92%
10-year revenue growth (CAGR)
18.66%
3-year earnings per share growth (CAGR)
81.41%
10-year earnings per share growth (CAGR)
53.38%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Formycon AG stock?
Formycon AG (FYB) has a market cap of €448M as of August 16, 2025.
What is the P/E ratio for Formycon AG stock?
The price to earnings (P/E) ratio for Formycon AG (FYB) stock is 0 as of August 16, 2025.
Does Formycon AG stock pay dividends?
No, Formycon AG (FYB) stock does not pay dividends to its shareholders as of August 16, 2025.
When is the next Formycon AG dividend payment date?
Formycon AG (FYB) stock does not pay dividends to its shareholders.
What is the beta indicator for Formycon AG?
Formycon AG (FYB) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.